Cellmid's LMU collaboration might be up to something. Here is a recent post by one of their researchers about their findings from earlier this year.
Midkine controls natural bypass growth by regulating the bioavailability of VEGF
"...midkine might present a drug superior to currently available vasodilators such as nitric oxide donors, which only show a limited effect due to rapid tolerance."
The Atlas of Science: is made by scientists for scientists. The aim of the project is publishing layman's abstracts of research articles.
